News

Yahoo Finance23d
Dexcom’s FDA warning letter reveals unauthorized changes to sensors
A warning letter posted Tuesday by the Food and Drug Administration revealed quality control issues with Dexcom’s continuous glucose monitors. The FDA raised concerns with a design change to a ...
WKRG on MSN7h
FDA hiring contractors to replace terminated safety inspection staffers
When Health Secretary Robert F. Kennedy Jr. announced sweeping job cuts at his department last month, he said that safety ...
ROSEN, A LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
New York, New York-- (Newsfile Corp. - April 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 ...
VTRS INVESTOR REMINDER: Viatris Inc. Investors have until June 3 to Contact BFA Law about the Securities Fraud Class Action
New York, New York-- (Newsfile Corp. - April 17, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain ...
Investopedia8d
FDA Approves New DexCom Diabetes Device
They have lost more than 50% of their value over the past year. A month ago, the firm received a warning letter from the FDA over the condition of two of its manufacturing plants. Investopedia ...
WTVD2d
Counterfeit Ozempic: FDA sounds the alarm, warns consumers about fake weight loss drugs
NORTH CAROLINA (WTVD) -- A warning to consumers about fake Ozempic (semaglutide). The FDA issued this alert saying counterfeits have been found in the US drug supply chain. The FDA and the ...
FDA uncovers ‘significant’ data falsification by Indian company, rejects all studies
FDA rejects all in vitro study data from Raptim Research due to data falsification, requiring companies to redo studies ...